28
mar
2019
We welcome our new owners
We would like to welcome our new international- as well as Scandinavian owners after closing this funding round.
News
07
mar
2019
New collaboration with Pharma
Oblique Therapeutics has entered into a collaboration agreement with a mid-sized Pharma for the development of the TRPV1 antibody.
